| scholarly article | Q13442814 |
| P356 | DOI | 10.1210/JC.2002-021732 |
| P698 | PubMed publication ID | 14671170 |
| P2093 | author name string | Ralph Fingerhut | |
| Bernhard Olgemöller | |||
| Adelbert A Roscher | |||
| Bernhard Liebl | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | congenital adrenal hyperplasia | Q366868 |
| birth mass | Q4128476 | ||
| P304 | page(s) | 5790-5794 | |
| P577 | publication date | 2003-12-01 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | Screening for congenital adrenal hyperplasia: adjustment of 17-hydroxyprogesterone cut-off values to both age and birth weight markedly improves the predictive value | |
| P478 | volume | 88 |
| Q47185895 | A newborn screening system based on service-oriented architecture embedded support vector machine |
| Q35863921 | Adrenal steroidogenesis and congenital adrenal hyperplasia |
| Q89668860 | Adverse Outcomes and Economic Burden of Congenital Adrenal Hyperplasia Late Diagnosis in the Newborn Screening Absence |
| Q50024650 | Children with premature pubarche: is an alterated neonatal 17-Ohp screening test a predictive factor? |
| Q30433566 | Combined deletion of Fxr and Shp in mice induces Cyp17a1 and results in juvenile onset cholestasis |
| Q57068342 | Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline |
| Q34602068 | Congenital adrenal hyperplasia and P450 oxidoreductase deficiency |
| Q24614223 | Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline |
| Q36802670 | Congenital adrenal hyperplasia: an update in children |
| Q38164270 | Congenital adrenal hyperplasia: issues in diagnosis and treatment in children |
| Q48218571 | Development of CYP21A2 Genotyping Assay for the Diagnosis of Congenital Adrenal Hyperplasia |
| Q51755510 | Expanded newborn screening in Greece: 30 months of experience. |
| Q36265163 | Guidelines for diagnosis and treatment of 21-hydroxylase deficiency (2014 revision) |
| Q58025031 | Lessons learned from 5 years of newborn screening for congenital adrenal hyperplasia in the Czech Republic: 17-hydroxyprogesterone, genotypes, and screening performance |
| Q51009845 | Neonatal 17-hydroxyprogesterone levels adjusted according to age at sample collection and birthweight improve the efficacy of congenital adrenal hyperplasia newborn screening. |
| Q84427406 | Neonatal screening for congenital adrenal hyperplasia |
| Q46428052 | Neonatal screening for congenital adrenal hyperplasia in North-Eastern Italy: a report three years into the program |
| Q36251774 | Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants. |
| Q62724491 | Newborn Screening Healthcare Information System Based on Service-Oriented Architecture |
| Q39207166 | Newborn Screening for Congenital Adrenal Hyperplasia in India: What Do We Need to Watch Out for? |
| Q37004707 | Newborn screening for congenital adrenal hyperplasia in New York State |
| Q54608998 | No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening. |
| Q39843555 | Preliminary report on neonatal screening for congenital hypothyroidism, congenital adrenal hyperplasia and glucose-6-phosphate dehydrogenase deficiency: a Chandigarh experience. |
| Q58025156 | Prevalence of congenital adrenal hyperplasia among sudden infant death in the Czech Republic and Austria |
| Q57063630 | Primary amenorrhoea and clitoromegaly in a nulliparous woman: successful medical and surgical management |
| Q35680882 | Profiles of 21-Carbon Steroids in 21-hydroxylase Deficiency |
| Q37228691 | Progress in molecular-genetic studies on congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency |
| Q53230881 | Quality performance of newborn screening systems: strategies for improvement. |
| Q46571846 | Serum 17 alpha hydroxyprogesterone in normal full term and preterm vs sick preterm and full term newborns in a tertiary hospital |
| Q37242225 | The clinical and biochemical spectrum of congenital adrenal hyperplasia secondary to 21-hydroxylase deficiency. |
| Q39143928 | The influence of seasonality and manufacturer kit lot changes on 17α-hydroxyprogesterone measurements and referral rates of congenital adrenal hyperplasia in newborns |
| Q36055119 | The next 150 years of congenital adrenal hyperplasia |
| Q34977544 | Use of steroid profiling by UPLC-MS/MS as a second tier test in newborn screening for congenital adrenal hyperplasia: the Utah experience |
Search more.